Inhibition of neuroinflammation prevents injury to the serotonergic network after hypoxia-ischemia in the immature rat brain

Journal of Neuropathology and Experimental Neurology

Volumn 70, Issue 1, 2011, Pages 23-35

  Wixey, Julie A ^a   Reinebrant, Hanna E ^a   Buller, Kathryn M ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Hypoxia ischemia; Microglia; Neonatal; Neuroinflammation; Raphe; Serotonin; Serotonin transporter

Indexed keywords

INTERLEUKIN 1BETA; MINOCYCLINE; SEROTONIN; SEROTONIN TRANSPORTER; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN HYPOXIA; BRAIN ISCHEMIA; CELL ACTIVATION; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; ENCEPHALITIS; MICROGLIA; NERVE CELL NETWORK; NONHUMAN; PHENOTYPE; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEROTONIN BRAIN LEVEL; SEROTONINERGIC SYSTEM;

ANIMALS; ANIMALS, NEWBORN; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; HYPOXIA-ISCHEMIA, BRAIN; INFLAMMATION; INFLAMMATION MEDIATORS; MINOCYCLINE; NERVE NET; PROSENCEPHALON; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA-BINDING PROTEINS; SEROTONIN;

EID: 78650678714     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3182020b7b     Document Type: Article

References (88)

1. Hornung JP. The human raphe nuclei and the serotonergic system. J Chem Neuroanat 2003;26:331-43
2. Popa D, Lena C, Alexandre C, et al. Lasting syndrome of depression produced by reduction in serotonin uptake during postnatal development: Evidence from sleep, stress, and behavior. J Neurosci 2008;28: 3546-54
3. Murphy DL, Lerner A, Rudnick G, et al. Serotonin transporter: Gene, genetic disorders, and pharmacogenetics. Mol Interv 2004;4:109-23
4. Paterson DS, Trachtenberg FL, Thompson EG, et al. Multiple seroto-nergic brainstem abnormalities in sudden infant death syndrome. JAMA 2006;296:2124-32
5. Ferriero DM. Neonatal brain injury. N Engl J Med 2004;351:1985-95
6. Peterson BS, Anderson AW, Ehrenkranz R, et al. Regional brain volumes and their later neurodevelopmental correlates in term and preterm infants. Pediatrics 2003;111:939-48
7. Anderson P, Doyle LW. Neurobehavioural outcomes of school-age children born extremely low birth weight or very preterm in the 1990s. JAMA 2003;289:3264-72
8. Hack M, Youngstrom EA, Cartar L, et al. Behavioral outcomes and evidence of psychopathology among very low birth weight infants at age 20 years. Pediatrics 2004;114:932-40
9. Hayashi M, Itoh M, Araki S, et al. Immunohistochemical analysis of brainstem lesions in infantile spasms. Neuropathology 2000;20:297-303
10. Duncan JR, Paterson DS, Hoffman JM, et al. Brainstem serotonergic deficiency in sudden infant death syndrome. JAMA 2010;303:430-37
11. Logitharajah P, Rutherford MA, Cowan FM. Hypoxic-ischemic ence-phalopathy in preterm infants: Antecedent factors, brain imaging, and outcome. Pediatr Res 2009;66:222-29
12. Reinebrant HE, Wixey JA, Colditz PB, et al. Differential effects of neonatal hypoxic-ischemic brain injury on brainstem serotonergic raphe nuclei. Brain Res 2010;1322:124-33
13. Biran V, Joly L-M, Heron A, et al. Glial activation in white matter following ischemia in the neonatal P7 rat brain. Exp Neurol 2006;199: 103-12
14. Farkas E, Donka G, de Vos RAI, et al. Experimental cerebral hypo-perfusion induces white matter injury and microglial activation in the rat brain. Acta Neuropathol 2004;108:57-64
15. Ivacko JA, Sun R, Silverstein FS. Hypoxic-ischemic brain injury induces an acute microglial reaction in perinatal rats. Pediatr Res 1996;39:39-47
16. McRae A, Gilland E, Bona E, et al. Microglia activation after neonatal hypoxic-ischemia. Dev Brain Res 1995;84:245-52
17. Yrjanheikki J, Keinanen R, Pellikka M, et al. Tetracyclines inhibit micro-glial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 1998;95:15769-74
18. Tomas-Camardiel M, Rite I, Herrera AJ, et al. Minocycline reduces the lipopolysaccharide-induced inflammatory reaction, peroxynitrite-mediated nitration of proteins, disruption of the blood-brain barrier, and damage in the nigral dopaminergic system. Neurobiol Dis 2004;16:190-201
19. Arvin KL, Han BH, Du J, et al. Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. Ann Neurol 2002;52: 54-61
20. Carty ML, Wixey JA, Colditz PB, et al. Post-hypoxia-ischemia minocy-cline treatment attenuates neuroinflammation and white matter injury in the neonatal rat; a comparison of two different dose regimens. Int J Dev Neurosci 2008;26:477-85
21. Cai Z, Lin S, Fan L-W, et al. Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain. Neuroscience 2006;137:425-35
22. Fan L-W, Lin S, Pang Y, et al. Minocycline attenuates hypoxia-ischemia-induced neurological dysfunction and brain injury in the juvenile rat. Eur J Neurosci 2006;24:341-50
23. Ahuja M, Bishnoi M, Chopra K. Protective effect of minocycline, a semi-synthetic second-generation tetracycline against 3-nitropropionic acid (3-NP)-induced neurotoxicity. Toxicology 2008;244:111-22
24. Zhang L, Shirayama Y, Shimizu E, et al. Protective effects of minocy-cline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain. Eur J Pharmacol 2006;544:1-9
25. Traynor BJ, Bruijn L, Conwit R, et al. Neuroprotective agents for clinical trials in ALS: a systematic assessment. Neurology 2006;67:20-27
26. Fleischer ABJ, Dinehart S, Stough D, et al. Safety and efficacy of a new extended-release formulation of minocycline. Cutis 2006;78:21-31
27. Lampl Y, Boaz M, Gilad R, et al. Minocycline treatment in acute stroke: An open-label, evaluator-blinded study. Neurology 2007;69:1404-10
28. Fanning WL, Gump DW, Sofferman IRA. Side effects of minocycline: A double-blind study. Antimicrob Agents Chemother 1977;11:712-17
29. Gump DW, Ashikaga T, Fink TJ, et al. Side effects of minocycline: Different dosage regimens. Antimicrob Agents Chemother 1977;12:642-46
30. Laurence DR, Bennett PN. Clinical Pharmacology. 6th Ed. New York, NY: Churchill Livingstone, 1987
31. Buller KM, Carty ML, Reinebrant HE et al. Minocycline: A neuro-protective agent for hypoxic-ischemic brain injury in the neonate? J Neurosci Res 2009;87:599-608
32. Buller KM, Wixey JA, Pathipati P, et al. Selective losses of brainstem catecholamine neurons after hypoxia-ischemia in the immature rat pup. Pediatr Res 2008;63:364-69
33. Clancy B, Darlington RB, Finlay BL. Translating developmental time across mammalian species. Neuroscience 2001;105:7-17
34. Hagberg H, Peebles D, Mallard C. Models of white matter injury: Comparison of infectious, hypoxic-ischemic, and excitotoxic insults. Ment Retard Dev Disabil Res Rev 2002;8:30-38
35. Back SA, Luo NL, Borenstein NS, et al. Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury. J Neurosci 2001;21:1302-12
36. Marin-Padilla M. Developmental neuropathology and impact of perinatal brain damage. III: Gray matter lesions of the neocortex. J Neuropath Exp Neurol 1999;58:407-29
37. Sizonenko SV, Sirimanne E, Mayall Y, et al. Selective cortical alteration after hypoxic-ischemic injury in the very immature rat brain. Pediatr Res 2003;54:263-69
38. Fagan SC, Edwards DJ, Borlongan CV, et al. Optimal delivery of min-ocycline to the brain: Implication for human studies of acute neuro-protection. Exp Neurol 2004;186:248-51
39. Brogden RN, Speight TM, Avery GS. Minocycline: A review of its antibacterial and pharmacokinetic properties and therapeutic use. Drugs 1975; 9:251-91
40. Macdonald H, Kelly RG, Allen ES, et al. Pharmacokinetic studies on minocycline in man. Clin Pharmacol Ther 1973;14:852-61
41. Yrjanheikki J, Tikka T, Keinanen R, et al. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc Natl Acad Sci USA 1999;96:13496-500
42. Wixey JA, Reinebrant HE, Carty ML, et al. Delayed P2X4R expression after hypoxia-ischemia is associated with microglia in the immature rat brain. J Neuroimmunol 2009;212:35-43
43. Smith DW, Buller KM, Day TA. Role of ventrolateral medulla catecho-lamine cells in hypothalamic neuroendocrine cell responses to systemic hypoxia. J Neurosci 1995;15:7979-88
44. Buller KM, Smith DW, Day TA. NTS catecholamine cell recruitment by hemorrhage and hypoxia. Neuroreport 1999;10:3853-56
45. Buller KM, Day TA. Systemic administration of interleukin-1A activates select populations of central amygdala afferents. J Comp Neurol 2002;452:288-96
46. Imai Y, Ibata I, Ito D, et al. A novel gene iba1 in the major histocom-patibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Comm 1996;224:855-62
47. Imai Y, Kohsaka S. Intracellular signaling in M-CSF-induced microglia activation: Role of Iba1. Glia 2002;40:164-74
48. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic Press, 1997
49. Zhou FC, Tao-Cheng J-H, Segu L, et al. Serotonin transporters are located on the axons beyond the synaptic junctions: Anatomical and functional evidence. Brain Res 1998;805:241-54
50. Smith HR, Porrino LJ. The comparative distributions of the monoamine transporters in the rodent, monkey, and human amygdala. Brain Struct Funct 2008;213:73-91
51. Yamamoto H, Fujimiya M, Shirai Y, et al. Immunohistochemical localization of serotonin transporter in normal and colchicine treated rat brain. Neurosci Res 1998;32:305-12
52. Michelsen KA, Schmitz C, Steinbusch HW. The dorsal raphe nucleus-from silver stainings to a role in depression. Brain Res Rev 2007;55: 329-42
53. Kanno K, Shima S, Ishida Y, et al. Ipsilateral and contralateral serotonergic projections from dorsal and median raphe nuclei to the forebrain in rats: Immunofluorescence quantitative analysis. Neurosci Res 2008;61:207-18
54. Vertes RP. A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat. J Comp Neurol 1991;313:643-68
55. Imai H, Steindler DA, Kitai ST. The organization of divergent axonal projections from the midbrain raphe nuclei in the rat. J Comp Neurol 1986;243:363-80
56. Stadlin A, James A, Fiscus R, et al. Development of a postnatal 3-day-old rat model of mild hypoxic-ischemic brain injury. Brain Res 2003;993:101-10
57. Towfighi J, Yager JY, Housman C, et al. Neuropathology of remote hypoxic-ischemic damage in the immature rat. Acta Neuropathol 1991; 81:578-87
58. Fan L-W, Lin S-Z, Pang Y, et al. Hypoxia-ischemia induced neurological dysfunction and brain injury in the neonatal rat. Behav Brain Res 2005; 165:80-90 (Pubitemid 41476207)
59. Williams SM, Bryan-Lluka LJ, Pow DV. Quantitative analysis of immu-nolabeling for serotonin and for glutamate transporters after administration of imipramine and citalopram. Brain Res 2005;1042:224-32
60. Kreutzberg GW. Microglia: A sensor for pathological events in the CNS. Trend Neurosci 1996;19:312-18
61. Sur C, Betz H, Schloss P. Immunocytochemical detection of the serotonin transporter in rat brain. Neuroscience 1996;73:217-31
62. Kosofsky BE, Molliver ME. The serotonergic innervation of cerebral cortex: Different classes of axon terminals arise from dorsal and median raphe nuclei. Synapse 1987;1:153-68
63. Takeuchi Y, Fujiwara K, Ishimura K, et al. Effects of neonatal asphyxia on the serotonin neuron system in the developing brain studied by im-munohistochemistry. Dev Neurosci 1992;14:394-402
64. Hadjiconstantinou M, Yates AJ, Neff NH. Hypoxia-induced neuro-transmitter deficits in neonatal rats are partially corrected by exogenous GM1 ganglioside. J Neurochem 1990;55:864-69
65. Vannucci RC, Lyons DT, Vasta F. Regional cerebral blood flow during hypoxia-ischemia in immature rats. Stroke 1988;19:245-50
66. Hagberg H, Gilliaud E, Bona E. Enhanced expression of IL1 and IL6 mRNA and bioactive proteins after hypoxia ischemia in neonatal rats. Pediatr Res 1996;40:603-9
67. Silveira RC, Procianoy RS. Interleukin-6 and tumour necrosis factor-> levels in plasma and cerebral spinal fluid of term newborn infants with hypoxic-ischemic encephalopathy. J Pediatr 2003;143:625-29
68. Huh Y, Jung JW, Park C, et al. Microglial activation and tyrosine hydroxylase immunoreactivity in the substantia nigral region following transient focal ischemia in rats. Neurosci Lett 2003;349:63-67
69. Kadhim H, Tabarki B, Verellen G, et al. Inflammatory cytokines in the pathogenesis of periventricular leukomalacia. Neurology 2001;56:1278-84
70. Loos M, Dihne M, Block F. Tumor necrosis factor-[alpha] expression in areas of remote degeneration following middle cerebral artery occlusion of the rat. Neuroscience 2003;122:373-80
71. Bartha AI, Miller SP, Foster-Barber A, et al. Cytokines are associated with cerebral metabolism and outcome in term neonatal encephalopathy. Dev Neurosci 2005;27:270
72. Bona E, Andersson AL, Blomgren K, et al. Chemokine and inflammatory cell response to hypoxia ischemia in immature rats. Pediatr Res 1999;45: 500-9
73. Kremlev SG, Roberts RL, Palmer C. Minocycline modulates chemokine receptors but not interleukin-10 mRNA expression in hypoxic-ischemic neonatal rat brain. J Neurosci Res 2007;85:2450-59
74. Wasserman JK, Schlichter LC. Minocycline protects the blood-brain barrier and reduces edema following intracerebral hemorrhage in the rat. Exp Neurol 2007;207:227-37
75. Nagel S, Su Y, Horstmann S, et al. Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat-Effects on BBB breakdown and MMP expression in the acute and subacute phase. Brain Res 2008;1188:198-206
76. Machado LS, Kozak A, Ergul A, et al. Delayed minocycline inhibits ischemia-activated matrix metalloproteinases 2 and 9 after experimental stroke. BMC Neurosci 2006;7:56
77. Wang J, Wei Q, Wang CY, et al. Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria. J Biol Chem 2004;279: 19948-54
78. O'Brien F, Roth S, Stewart A, et al. The neurodevelopmental progress of infants less than 33 weeks into adolescence. Arch Dis Child 2004;89: 207-11
79. Marlow N, Rose AS, Rands CE, et al. Neuropyschological and educational problems at school age associated with neonatal encephalopathy. Arch Dis Child 2005;90:380-87
80. Arborelius L, Eklund MB. Both long and brief maternal separation produces persistent changes in tissue levels of brain monoamines in middle-aged female rats. Neuroscience 2007;145:738-50
81. Smythe JW, Rowe WB, Meaney MJ. Neonatal handling alters serotonin (5-HT) turnover and 5-HT2 receptor binding in selected brain regions: Relationship to the handling effect on glucocorticoid receptor expression. Brain Res Dev Brain Res 1994;80:183-89
82. Gartside SE, Johnson DA, Leitch MM, et al. Early life adversity programs changes in central 5-HT neuronal function in adulthood. Eur J Neurosci 2003;17:2401-8
83. Paterson DS, Belliveau RA, Trachtenberg F, et al. Differential development of 5-HT receptor and the serotonin transporter binding in the human infant medulla. J Comp Neurol 2004;472:221-31
84. Kinney HC, Richerson GB, Dymecki SM, et al. The brainstem and serotonin in the Sudden Infant Death Syndrome. Ann Rev Pathol 2009;4: 517-50
85. Malloy MH, Hoffman HJ. Prematurity, sudden infant death syndrome, and age of death. Pediatrics 1995;96:464-71
86. Lin S, Wei X, Bales KR, et al. Minocycline blocks bilirubin neurotoxicity and prevents hyperbilirubinemia-induced cerebellar hypoplasia in the Gunn rat. Eur J Neurosci 2005;22:21-27
87. Geiger AS, Rice AC, Shapiro SM. Minocycline blocks acute bilirubin-induced neurological dysfunction in jaundiced Gunn rats. Neonatology 2007;92:219-26
88. Shapiro SM, Bhutani VK, Johnson L. Hyperbilirubinemia and kernicte-rus. Clin Perinatol 2006;33:387-410